Readystate Asset Management’s Vera Therapeutics VERA Stock Holding History

Readystate Asset Management’s Portfolio VERA Stock Details VERA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12.7M	Buy	+295,114	New	+$11M	0.43%	59
2025 Q3	–	Sell	-401,427	Closed	-$9.46M	–	702
2025 Q2	$9.46M	Buy	+401,427	New	+$9.03M	0.29%	74
2025 Q1	–	Sell	-189,088	Closed	-$8M	–	756
2024 Q4	$8M	Buy	189,088 +141,405	+297%	+$6.26M	0.25%	92
2024 Q3	$2.11M	Sell	47,683 -724,992	-94%	-$27.5M	0.04%	358
2024 Q2	$28M	Buy	772,675 +178,584	+30%	+$7.08M	0.91%	20
2024 Q1	$25.6M	Buy	+594,091	New	+$21.2M	0.36%	31

Other funds holding VERA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Readystate Asset Management's VERA Position: Q2 2026 in Review

Readystate Asset Management opened a new position in Vera Therapeutics (VERA) in Q2 2026: 295,114 shares worth $12.7M. The stake represents 0.43% of the portfolio and ranks #59 among its holdings. This is a return to the name: Readystate Asset Management previously reported a position in VERA as recently as Q2 2025.

Readystate Asset Management first reported a position in VERA in Q1 2024 and has held it in 6 quarters since. The position peaked at $28M in Q2 2024. 220 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

Readystate Asset Management held 295,114 shares of Vera Therapeutics worth $12.7M as of Q2 2026.
Vera Therapeutics was a new Readystate Asset Management position in Q2 2026.
Vera Therapeutics made up 0.43% of Readystate Asset Management's portfolio in Q2 2026, its #59 holding.
Readystate Asset Management first reported a position in Vera Therapeutics in Q1 2024 and has held it in 6 quarters since.
Readystate Asset Management's Vera Therapeutics position peaked at $28M in Q2 2024.
220 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Readystate Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.